A PHASE IIB TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF ONY-P VACCINES IN THE MANAGEMENT OF PROSTATE CANCER WITHOUT DETECTABLE METASTASES FOLLOWING INITIAL ESCAPE FROM HORMONE TREATMENT
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Prostate cancer vaccine (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Onyvax
- 22 Jun 2011 New source identified and integrated (European Clinical Trials Database record EudraCT2006-001619-31).
- 17 Mar 2008 The primary endpont is expected to be reached in the first half of 2009, as reported in an Onyvax media release.
- 08 Aug 2006 New trial record.